Literature DB >> 21631698

Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.

Ricardo L Favaretto1, Shahrokh F Shariat, Caroline Savage, Guilherme Godoy, Daher C Chade, Matthew Kaag, Bernard H Bochner, Jonathan Coleman, Guido Dalbagni.   

Abstract

OBJECTIVE: To create a preoperative multivariable model to identify patients at risk of muscle-invasive (pT2+) upper tract urothelial carcinoma (UTUC) and/or non-organ confined (pT3+ or N+) UTUC (NOC-UTUC) who potentially could benefit from radical nephroureterectomy (RNU), neoadjuvant chemotherapy and/or an extended lymph node dissection. PATIENTS AND METHODS: We retrospectively analysed data from 324 consecutive patients treated with RNU between 1995 and 2008 at a tertiary cancer centre. Patients with muscle-invasive bladder cancer were excluded, resulting in 274 patients for analysis. Logistic regression models were used to predict pT2+ and NOC-UTUC. Pre-specified predictors included local invasion (i.e. parenchymal, renal sinus fat, or periureteric) on imaging, hydronephrosis on imaging, high-grade tumours on ureteroscopy, and tumour location on ureteroscopy. Predictive accuracy was measured by the area under the curve (AUC).
RESULTS: The median follow-up for patients without disease recurrence or death was 4.2 years. Overall, 49% of the patients had pT2+, and 30% had NOC-UTUC at the time of RNU. In the multivariable analysis, only local invasion on imaging and ureteroscopy high grade were significantly associated with pathological stage. AUC to predict pT2+ and NOC-UTUC were 0.71 and 0.70, respectively.
CONCLUSIONS: We designed a preoperative prediction model for pT2+ and NOC-UTUC, based on readily available imaging and ureteroscopic grade. Further research is needed to determine whether use of this prediction model to select patients for conservative management vs RNU, neoadjuvant chemotherapy, and/or extended lymphadenectomy will improve patient outcomes.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21631698      PMCID: PMC4319659          DOI: 10.1111/j.1464-410X.2011.10288.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  33 in total

1.  Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison.

Authors:  S Moussa; F A Yafi; A El-Hakim; N Fahmy; A Aprikian; S Tanguay; M Anidjar; W Kassouf
Journal:  Urol Int       Date:  2010-02-17       Impact factor: 2.089

Review 2.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

3.  Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract.

Authors:  Sang Eun Lee; Seok-Soo Byun; Yong Hyun Park; In Ho Chang; Yong June Kim; Sung Kyu Hong
Journal:  Urol Int       Date:  2006       Impact factor: 2.089

4.  Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.

Authors:  Matthew G Kaag; Rebecca L O'Malley; Padraic O'Malley; Guilherme Godoy; Mang Chen; Marc C Smaldone; Ronald L Hrebinko; Jay D Raman; Bernard Bochner; Guido Dalbagni; Michael D Stifelman; Samir S Taneja; William C Huang
Journal:  Eur Urol       Date:  2010-06-25       Impact factor: 20.096

5.  Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy.

Authors:  Brian R Lane; Armine K Smith; Benjamin T Larson; Michael C Gong; Steven C Campbell; Derek Raghavan; Robert Dreicer; Donna E Hansel; Andrew J Stephenson
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

6.  Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma.

Authors:  M J Scolieri; M L Paik; S L Brown; M I Resnick
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

7.  Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.

Authors:  Mesut Remzi; Andrea Haitel; Vitaly Margulis; Pierre Karakiewicz; Pierre Karakiewizc; Francesco Montorsi; Eiji Kikuchi; Richard Zigeuner; Alon Weizer; Christian Bolenz; Karim Bensalah; Nazareno Suardi; Jay D Raman; Yair Lotan; Matthias Waldert; Casey K Ng; Mario Fernández; Theresa M Koppie; Philipp Ströbel; Wareef Kabbani; Masaru Murai; Cord Langner; Marco Roscigno; Jeffrey Wheat; Charles C Guo; Christopher G Wood; Shahrokh F Shariat
Journal:  BJU Int       Date:  2008-10-16       Impact factor: 5.588

8.  Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.

Authors:  Mario I Fernández; Shahrokh F Shariat; Vitaly Margulis; Christian Bolenz; Francesco Montorsi; Nazareno Suardi; Mesut Remzi; Christopher G Wood; Marco Roscigno; Eiji Kikuchi; Mototsugu Oya; Richard Zigeuner; Cord Langner; Alon Weizer; Yair Lotan; Theresa M Koppie; Jay D Raman; Pierre Karakiewicz; Pierre Karakiewizc; Karim Bensalah; Marcela Schultz; Pablo Bernier
Journal:  Urology       Date:  2008-10-08       Impact factor: 2.649

9.  Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?

Authors:  Casey K Ng; Shahrokh F Shariat; Steven M Lucas; Aditya Bagrodia; Yair Lotan; Douglas S Scherr; Jay D Raman
Journal:  Urol Oncol       Date:  2008-12-30       Impact factor: 3.498

10.  Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy.

Authors:  Shahrokh F Shariat; Guilherme Godoy; Yair Lotan; Michael Droller; Pierre I Karakiewicz; Jay D Raman; Hendrik Isbarn; Alon Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Christian Bolenz; Karim Bensalah; Theresa M Koppie; Wassim Kassouf; Jeffrey C Wheat; Richard Zigeuner; Cord Langner; Christopher G Wood; Vitaly Margulis
Journal:  BJU Int       Date:  2009-11-13       Impact factor: 5.588

View more
  58 in total

1.  Urothelial carcinoma: Endoscopy to predict outcomes in upper tract urothelial cancer.

Authors:  Ramy F Youssef; Vitaly Margulis
Journal:  Nat Rev Urol       Date:  2012-04-03       Impact factor: 14.432

Review 2.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

3.  Systemic chemotherapy and radical nephroureterectomy.

Authors:  Syed M Jafri; Jay D Raman
Journal:  Int Urol Nephrol       Date:  2015-04-16       Impact factor: 2.370

4.  Tumour architecture, grade and location remain predictors of non-organ-confined upper tract urothelial carcinoma at time of radical nephroureterectomy: results from a multicenter Norwegian external validation study.

Authors:  Bjarte Almås; Stein Øverby; Ole J Halvorsen; Lars A R Reisæter; Jørg Assmus; Birgitte Carlsen; Anders Loe; Christian Beisland
Journal:  World J Urol       Date:  2019-05-23       Impact factor: 4.226

Review 5.  Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma.

Authors:  Evanguelos Xylinas; Luis Kluth; Sibani Mangal; Morgan Roupret; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  World J Urol       Date:  2012-09-18       Impact factor: 4.226

6.  Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy.

Authors:  Sophie Hurel; Morgan Rouprêt; Thomas Seisen; Eva Comperat; Véronique Phé; Stéphane Droupy; François Audenet; Géraldine Pignot; Xavier Cathelineau; Laurent Guy; Olivier Cussenot; Adil Ouzzane; Gregory Bozzini; Laurent Nison; Alain Ruffion; Pierre Colin
Journal:  World J Urol       Date:  2014-05-09       Impact factor: 4.226

7.  Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report.

Authors:  Soichiro Yoshida; Shuichiro Kobayashi; Fumitaka Koga; Junichiro Ishioka; Chikako Ishii; Hiroshi Tanaka; Yasukazu Nakanishi; Yoh Matsuoka; Noboru Numao; Kazutaka Saito; Hitoshi Masuda; Yasuhisa Fujii; Kazunori Kihara
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

Review 8.  A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting.

Authors:  Sarah J Drouin; David R Yates; Vincent Hupertan; Olivier Cussenot; Morgan Rouprêt
Journal:  World J Urol       Date:  2012-12-18       Impact factor: 4.226

9.  Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort.

Authors:  G Bozzini; L Nison; P Colin; A Ouzzane; D R Yates; F Audenet; G Pignot; A Arvin-Berod; O Merigot; L Guy; J Irani; F Saint; S Gardic; P Gres; F Rozet; Y Neuzillet; A Ruffion; M Roupret
Journal:  World J Urol       Date:  2012-10-11       Impact factor: 4.226

10.  The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.

Authors:  Laurent Nison; Morgan Rouprêt; Grégory Bozzini; Adil Ouzzane; François Audenet; Géraldine Pignot; Alain Ruffion; Jean-Nicolas Cornu; Sophie Hurel; Antoine Valeri; Mathieu Roumiguie; Thomas Polguer; Nicolas Hoarau; Olivier Mérigot de Treigny; Evanguelos Xylinas; Alexandre Matte; Stéphane Droupy; Pierre Olivier Fais; Aurélien Descazeaud; Pierre Colin
Journal:  World J Urol       Date:  2012-10-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.